Managing AMI – much work still to do? MONDAY, 28 th FEBRUARY – SESSION 3 Patrick Goldstein EXPERTS WORKSHOP ON EARLY TREATMENT STRATEGIES FOR ACUTE MYOCARDIAL.

Slides:



Advertisements
Similar presentations
Inequalities across Europe in access to primary angioplasty to treat acute heart attack patients -the cross-border dimension- John Martin, MD, FRCP, FESC,
Advertisements

BASE HOSPITAL GROUP ONTARIO Chapter 3 for 12 Lead Training -WHY 12 LEAD- Ontario Base Hospital Group Education Subcommittee 2008 TIME IS MUSCLE.
Acute Myocardial Infarction (AMI) JCAHO Core Measure Project Loyola University Medical Center Team Members: K. McLean MD, M. Morrow MSN, J. Cochran BSN,
Chapter 3 for 12 Lead Training -Precourse-
Inquiry into Public Hospital Performance Ambulance Victoria Presentation 2 December 2009.
D2B Strategies and the Role of the Emergency Department John J. Kelly DO, FACEP Associate Chair, Emergency Medicine Albert Einstein Medical Center Associate.
Regional Systems of Care to Optimize Timeliness of Reperfusion Therapy for STEMI: The Mayo Clinic Protocol Henry H. Ting, MD, MBA Associate Professor of.
OVERALL CATHETERIZATION LABORATORY NORMAL ANGIOGRAPHY RATE DOES NOT INCREASE WITH EMERGENCY ROOM ACTIVATION OF PRIMARY CORONARY INTERVENTION (PCI) FOR.
STEMI: What’s the Rush? STEMI: What’s the Rush? William Phillips, MD, FACC, FSCAI Director of Cardiology CMMC A PCI Center perspective.
Quality Improvement in the Emergency Department Creating the culture so it’s second nature Jonathan A. Edlow, MD Associate Professor of Medicine Harvard.
What can we do to cut down the time it takes to give a clot dissolving drug (tPA)?
Promoting Excellence in Cardiovascular Disease Prevention and Rehabilitation The BACPR Standards and Core Components for Cardiovascular Prevention and.
Systems in Acute Stroke Care Andy Jagoda, MD Professor of Emergency Medicine Department of Emergency Medicine Mount Sinai School of Medicine New York,
Primary PCI Treatment of choice for Acute MI.
Perspective on COMMIT/CCS-2 Trial of Clopidogrel in STEMI Christopher Cannon, M.D. Brigham and Women’s Hospital Boston, MA.
CRUSADE: A National Quality Improvement Initiative CRUSADE: A National Quality Improvement Initiative Can Rapid Risk Stratification of Unstable Angina.
GP IIb/IIIa Inhibition in STEMI: Growing Clinical Trial Evidence.
Ten Points to Remember from the 2007 STEMI Guideline Update Based on the 2007 Focused Update of the 2004 Guidelines for the Management of Patients With.
ACS and Thrombosis in the Emergency Setting
Partner meeting Aprile, Alberto Cremonesi.
Ambulance Victoria and MonashHEART Acute Myocardial Infarction (Mon-AMI) 12 lead ECG project. An update On behalf of the MonAMI Team A Hutchison, Y Malaiapan,
A Regional Approach to Improvement Julie Branter Associate Director for Clinical Governance and Patient Safety 21 September 2010 South West Strategic Health.
The Impact of Regional ST-Elevation Myocardial Infarction Systems of Care on the Use of Protocols and Quality Improvement Initiatives in Community Hospitals.
Quality of care: from theory to practice Kim A Eagle MD Albion Walter Hewlett Professor of Internal Medicine Chief, Clinical Cardiology Co-Director, Heart.
Role of Percutaneous coronary intervention (PCI) after thrombolytic therapy By Dr. Mohamed Mahros Assistant lecturer of cardiology Benha faculty of medicine.
HORIZONS AMI Trial H armonizing O utcomes with R evascular IZ ati ON and S tents In A cute M ycoardial I nfarction H armonizing O utcomes with R evascular.
Virginia Heart Attack Coalition/Mission Lifeline.
Initiating Antiplatelet Therapy in Patients with Atherothrombosis
National AMI Information Call February 5, 2008 Patient Safety Initiative.
ACTION Registry. Objectives of the NCDR Registries Provide data standardization Provide data that is –Relevant, Credible, Timely, Actionable Present real.
Nursing Process- Implementaton. Implementation Implementation is a category of nursing behavior in which the actions necessary for accomplishing the health.
Effect of Switching Antithrombin Agents for Primary Angioplasty in Acute Myocardial Infarction The HORIZONS-SWITCH Analysis HORIZONS AMI Dangas G, et al.
6/04 CRUSADE: A National Quality Improvement Initiative C an R apid Risk Stratification of U nstable Angina Patients S uppress AD verse Outcomes with E.
Prehospital ECGs for Acute Coronary Syndromes Summary and Comment by Aaron E. Bair, MD, MSc, FAAEM, FACEP Published in Journal Watch Emergency Medicine.
Safety and Efficacy of Intravenous Enoxaparin in Elective Percutaneous Coronary Intervention: an International Randomized Evaluation (STEEPLE) Presented.
Confidential. This presentation is provided for the recipient only and cannot be reproduced or shared without Tennova Healthcare, Inc.’s express consent.
Eddy Lang MD Attending Staff Emergency Department Jewish General Hospital Update in reperfusion therapy for acute myocardial infarction.
The Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction (ASSENT-4 PCI) Trial ASSENT- 4 PCI Trial Presented.
Safer Healthcare Now! Acute Myocardial Infarction Presented by Amanda Thompson, Safer Healthcare Now Facilitator.
PCI for STEMI Ari de la Hera, M.D..
ADMIRALADMIRAL Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up ADMIRAL Study ADMIRAL.
Detailed Profile Proposal for 2015/16 presented to the Cardiology Technical Committee Cardiology consultation and patology board – Workflow Definition.
The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007.
RACE: Reperfusion of acute myocardial infarction in North Carolina emergency departments Christopher Granger, MD Director, Cardiac Care Unit Duke University.
Bivalirudin: Myths vs Reality? Dr Reman McDonagh Nycomed UK Ltd Conflict of Interest: Senior Manager working for Nycomed UK Ltd.
Acute Myocardial Infarction February 8, 2006.
Canadian AMI Virtual Learning Collaborative Information Call May
Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2007 Focused Update of the ACC/AHA 2004 Guidelines.
High-risk ST elevation MI patients (>4 mm elevation), Sx < 12 hrs 5 PCI centers (n=443) and 22 referring hospitals (n=1,129), transfer in < 3 hrs High-risk.
Cross Economy Case Study Cardiology Pathway Redesign Over the last few years England has been experiencing increasing demands on its urgent and emergency.
SPEED : GUSTO-IV PILOT GUSTO-IV Pilot Trial. SPEED : GUSTO-IV PILOT Rationale for Combination Therapy in AMI Enhance Incidence and Speed of Reperfusion.
Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction (ASSENT-4 PCI) Trial ASSENT- 4 PCI Trial Presented at.
Rationale for the Clinical Evaluation of Combination GP IIb-IIIa Inhibitor and Low-Dose Fibrinolytic Therapy in ST-Elevation Myocardial Infarction.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Comprehensive Meta-Analysis of Safety and Efficacy.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship between heparin anticoagulation and.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence and Correlates of Drug-Eluting Stent Thrombosis.
From: Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention:
Kelowna General Hospital
Outcomes of a Pharmacoinvasive Strategy for Successful Versus Failed Fibrinolysis and Primary Percutaneous Intervention in Acute Myocardial Infarction.
Dartmouth Hitchcock Medical Center
Guidelines for the Management of Patients With ST- Elevation Myocardial Infarction Adapted from Focused Updates: ACC/AHA 2009.
M. Valgimigli University of Ferrara Italy
Eva Kline-Rogers RN, NP, AACC University of Michigan
Section F: Clinical guidelines
Figure 2 Ischaemic and bleeding outcomes in the major clinical trials
Figure 1 PCI strategies in patients with STEMI and multivessel disease
% Heparin + GPI IIb/IIIa Bivalirudin +
OASIS-5: Study Design Randomize N=20,078 Enoxaparin (N=10,021)
Effect of Additional Temporary Glycoprotein IIb-IIIa Receptor Inhibition on Troponin Release in Elective Percutaneous Coronary Interventions After Pretreatment.
Pre-hospital prediction of transmural myocardial infarction and the need of acute coronary reperfusion by an artificial neural network compared to real-time.
Presentation transcript:

Managing AMI – much work still to do? MONDAY, 28 th FEBRUARY – SESSION 3 Patrick Goldstein EXPERTS WORKSHOP ON EARLY TREATMENT STRATEGIES FOR ACUTE MYOCARDIAL INFARCTION FOR THE MIDDLE EAST COUNTRIES FEBRUARY 26 TH -28 TH 2005 / DUBAI, UAE SPONSORED BY BOEHRINGER INGELHEIM

Can We Now Imagine Where Are Our Different Roles in the Modern Management of Acute MI?

on scene at the dispatching center at the ER but is that all ? The EP Clearly Has a Place in the Treatment

…but the common aim of a multidisciplinary team implementing a strategy of participation and collaboration so acting on the emergency call: yes treating patients on scene: yes transporting patients in a difficult position: yes but It Is Not a Question of EP or Cardiologists…

Together promote clinical research create and maintain documentation build evaluation tools: common registers training for coronary emergencies ambulance crews paramedics nurses students physicians promote media campaigns promote new participative and combined strategies

Cardiology and Emergency Medicine Ann. Emerg. Med 2002 ; 39 : united we stand divided we fall W.B. GiblerDepartment of Emergency Medicine Cincinnati E.J. TopolDepartment of Cardiology Cleveland B. HolfroydDepartment of Emergency Medicine Edmonton P.W. ArmstrongDepartment of Emergency Medicine Edmonton

Study Design Randomise AMI open label ASA UFH (bolus) No lytic (Group B) ASA UFH (bolus) TNK (Group A) n = 2000 Cath lab Angiography / PCI (immediate) Stent / clopidogrel (optional) Heparin as routinely used NO GP IIb/IIIa inhibitors, (only bail-out at investig. discretion) Angiography / PCI (immediate) Stent / clopidogrel (optional) Heparin as routinely used GP IIb/IIIa inhibitors can be used at investig. discretion

Combined Therapy in the “Real World” Organise pre-hospital fibrinolysis Define High Volume Centers for rescue PCI Availability 24 h / 24 h Direct admission to Cath Lab Define candidates for combined therapy Written protocols Risk / Time to Cath Lab / Ambulance or helicopter Validate the strategy each year

Proposal Education of health care providers Clinical investigation Improving routine care Creation of site-specific and multicenter databases Subspecialisation within emergency medicine and cardiology

So...Some Keys to Success and… € or $ Enough health care providers Comprehensive institutions Evaluation Training and Teaching Information and Communication

Total Reperfusion PCI Fibrinolysis (Rogers et al. J Am Coll Cardiol 2000; 36: ) Reperfusion During the Last Decade % YEARS p =

Cardiologists and Emergency Physicians Definitive progress for the patients but maybe also for the doctors whose progress together is even better as they get to know each other better A lobby or a task force ? EUROPE AND UAE and may be the planet IS SO SMALL

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.